- Home
- RVSB vs TLSA Comparison
RVSB vs TLSA Comparison
Compare RVSB & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- TLSA
- Stock Information
- Founded
- RVSB 1923
- TLSA 2013
- Country
- RVSB United States
- TLSA United Kingdom
- Employees
- RVSB N/A
- TLSA N/A
- Industry
- RVSB Savings Institutions
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- TLSA Health Care
- Exchange
- RVSB Nasdaq
- TLSA Nasdaq
- Market Cap
- RVSB 99.6M
- TLSA 87.8M
- IPO Year
- RVSB 1993
- TLSA 2000
- Fundamental
- Price
- RVSB $4.74
- TLSA $1.20
- Analyst Decision
- RVSB
- TLSA
- Analyst Count
- RVSB 0
- TLSA 0
- Target Price
- RVSB N/A
- TLSA N/A
- AVG Volume (30 Days)
- RVSB 17.9K
- TLSA 145.8K
- Earning Date
- RVSB 10-24-2024
- TLSA 05-10-2024
- Dividend Yield
- RVSB 1.70%
- TLSA N/A
- EPS Growth
- RVSB N/A
- TLSA N/A
- EPS
- RVSB 0.05
- TLSA N/A
- Revenue
- RVSB $46,297,000.00
- TLSA N/A
- Revenue This Year
- RVSB N/A
- TLSA N/A
- Revenue Next Year
- RVSB $12.93
- TLSA N/A
- P/E Ratio
- RVSB $98.52
- TLSA N/A
- Revenue Growth
- RVSB N/A
- TLSA N/A
- 52 Week Low
- RVSB $3.30
- TLSA $0.41
- 52 Week High
- RVSB $6.57
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- RVSB 51.94
- TLSA 65.44
- Support Level
- RVSB $4.45
- TLSA $0.83
- Resistance Level
- RVSB $4.72
- TLSA $0.92
- Average True Range (ATR)
- RVSB 0.12
- TLSA 0.09
- MACD
- RVSB -0.00
- TLSA 0.03
- Stochastic Oscillator
- RVSB 61.43
- TLSA 84.52
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.